Last Close
73.79
Aug 14 • 3:59 PM ET Dollar change-2.05 Percentage change(-2.70%)
Aftermarket Close
74.00
Aftermarket • 7:59 PM ET Dollar change+0.21 Percentage change(0.28%)
Aug 13, 5:20 PMZoetis shares rise after the FDA grants emergency authorization for its Simparica TRIO dog pill to treat New World screwworm infestations.
Index
S&P 500
Market Cap
30.49B
Enterprise Value
38.05B
Income
2.62B
Sales
9.52B
Book/sh
7.60
Cash/sh
4.06
Employees
14500
IPO
Feb 01, 2013
P/E
12.14
Forward P/E
11.22
PEG
3.33
P/S
3.20
P/B
9.71
P/C
18.19
P/FCF
12.89
EV/EBITDA
9.36
EV/Sales
4.00
Quick Ratio
1.84
Current Ratio
3.08
Debt/Eq
2.93
LT Debt/Eq
2.93
Option/Short
Yes / Yes
EPS (ttm)
6.08
EPS next Y
6.58
EPS next Q
1.55
EPS this Y
-1.25%
EPS next Y
3.88%
EPS next 5Y
3.37%
EPS past 3/5Y
10.25% 11.96%
Sales past 3/5Y
5.42% 7.24%
EPS Y/Y TTM
4.54%
Sales Y/Y TTM
1.41%
EPS Q/Q
2.64%
Sales Q/Q
0.33%
Insider Own
0.57%
Insider Trans
-0.35%
Inst Own
100.32%
Inst Trans
-2.56%
ROA
17.70%
ROE
64.39%
ROIC
21.12%
Gross Margin
70.22%
Oper. Margin
37.65%
Profit Margin
27.49%
SMA20
-2.40%
SMA50
-3.46%
SMA200
-31.01%
Trades
Shs Outstand
414.15M
Shs Float
410.88M
52W High
160.48 -54.02%
52W Low
71.45 3.28%
Volatility
3.65% 3.69%
ATR (14)
2.98
RSI (14)
44.95
Beta
0.72
Rel Volume
0.63
Avg Volume
7.07M
Volume
4,455,348
Perf Week
1.56%
Perf Month
-4.06%
Perf Quarter
-2.24%
Perf Half Y
-41.27%
Perf YTD
-41.35%
Perf Year
-51.79%
Perf 3Y
-61.09%
Perf 5Y
-63.38%
Perf 10Y
41.96%
Prev Close
75.84
Price
73.79
Change %
-2.70%
Date Action Analyst Rating Change Price Target Change
Aug-06-26Downgrade William Blair Outperform → Mkt Perform
May-27-26Downgrade Argus Buy → Hold
Apr-15-26Initiated Citigroup Buy $145
Jan-22-26Downgrade Piper Sandler Overweight → Neutral $135
Dec-15-25Downgrade BofA Securities Buy → Neutral $135
Dec-09-25Initiated Barclays Equal Weight $136
Nov-21-25Initiated KeyBanc Capital Markets Sector Weight
Jul-17-25Downgrade Leerink Partners Outperform → Market Perform $155
Jun-18-25Downgrade Stifel Buy → Hold $160
Dec-02-24Initiated Leerink Partners Outperform $215
Aug-14-26 06:02PM
Aug-13-26 04:34PM
Aug-12-26 05:33PM
Aug-10-26 04:01PM
Aug-07-26 07:58PM
04:30PM Loading…
04:30PM
10:31AM
Aug-06-26 07:16PM
05:52PM
05:51PM
07:18AM
07:00AM
07:00AM
Jul-31-26 12:52PM
12:21PM
05:38PM Loading…
Jul-30-26 05:38PM
Jul-27-26 02:01PM
Jul-22-26 07:30AM
Jul-20-26 03:46AM
Jul-15-26 08:30AM
Jul-07-26 07:00AM
Jul-06-26 07:00AM
Jul-02-26 08:48PM
Jul-01-26 06:59AM
Jun-27-26 08:55PM
Jun-25-26 08:30AM
04:59AM
Jun-15-26 02:36AM
Jun-11-26 03:27AM
Jun-04-26 10:23AM
02:57AM Loading…
Jun-03-26 02:57AM
May-27-26 09:35AM
May-21-26 08:30AM
May-20-26 04:15PM
May-11-26 04:30PM
May-07-26 08:45PM
04:30PM
12:09PM
11:47AM
07:59AM
07:59AM
07:08AM
07:00AM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-02-26 08:30AM
Mar-23-26 01:38PM
Mar-16-26 04:19AM
Mar-14-26 02:49PM
Mar-12-26 08:30AM
Mar-06-26 09:40AM
09:30AM
07:54AM
Mar-05-26 08:30AM
Mar-02-26 07:00AM
04:07AM
Mar-01-26 05:06AM
Feb-27-26 04:51PM
11:00AM
05:29AM
Feb-26-26 11:03PM
Feb-24-26 04:22PM
09:50AM
08:30AM
Feb-23-26 10:57AM
Feb-19-26 12:38AM
Feb-18-26 10:05AM
09:40AM
04:01AM
Feb-13-26 04:57PM
07:13AM
12:35AM
Feb-12-26 04:15PM
04:05PM
01:24PM
12:32PM
10:30AM
09:30AM
08:45AM
08:10AM
07:46AM
07:38AM
07:05AM
07:00AM
05:36AM
04:50AM
Feb-10-26 10:09PM
10:00AM
Feb-09-26 11:30AM
10:22AM
09:15AM
08:55AM
Feb-06-26 08:57AM
Feb-05-26 04:15PM
12:22PM
10:00AM
09:50AM
Feb-04-26 02:18PM
Feb-03-26 06:15PM
11:40AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
CEO & DirectorMs. Kristin C. Peck
Executive VPMs. Roxanne Lagano
Scientific AdvisorDr. Robert J. Polzer Ph.D.
Executive VP & Chief Commercial OfficerMr. Jamie Brannan
Executive VP & Chief Digital and Technology OfficerMr. Keith Sarbaugh
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 04:35 PM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 04:35 PM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 07:26 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Option Exercise41.8320,000836,600121,337Feb 17 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Sale127.0520,0002,540,964101,337Feb 17 04:22 PM
Polzer Robert JOfficerFeb 17 '26Proposed Sale127.342,346298,742Feb 17 04:14 PM
PECK KRISTIN COfficerFeb 17 '26Proposed Sale127.0520,0002,540,964Feb 17 04:13 PM
Polzer Robert JOfficerFeb 13 '26Proposed Sale129.093,662472,728Feb 13 04:26 PM